Homer KL - Search Results

1

Performance of Anti-Topoisomerase I Antibody Testing by Multiple-Bead, Enzyme-Linked Immunosorbent Assay and Immunodiffusion in a University Setting.

Homer KL, Warren J, Karayev D, Khanna PP, Young A, Nagaraja V, Metzger AL, Khanna D. Homer KL, et al. J Clin Rheumatol. 2020 Apr;26(3):115-118. doi: 10.1097/RHU.0000000000000971. J Clin Rheumatol. 2020. PMID: 30585996 Free PMC article.

2

Reliability, construct validity and responsiveness to change of the PROMIS-29 in systemic sclerosis-associated interstitial lung disease.

Fisher CJ, Namas R, Seelman D, Jaafar S, Homer K, Wilhalme H, Young A, Nagaraja V, White ES, Schiopu E, Flaherty K, Khanna D. Fisher CJ, et al. Clin Exp Rheumatol. 2019 Jul-Aug;37 Suppl 119(4):49-56. Epub 2019 Sep 4. Clin Exp Rheumatol. 2019. PMID: 31498073 Free article.

3

Prevalence, Treatment, and Outcomes of Coexistent Pulmonary Hypertension and Interstitial Lung Disease in Systemic Sclerosis.

Young A, Vummidi D, Visovatti S, Homer K, Wilhalme H, White ES, Flaherty K, McLaughlin V, Khanna D. Young A, et al. Arthritis Rheumatol. 2019 Aug;71(8):1339-1349. doi: 10.1002/art.40862. Epub 2019 Jun 18. Arthritis Rheumatol. 2019. PMID: 30762947 Free PMC article.

4

Occupational Therapy Treatment to Improve Upper Extremity Function in Individuals with Early Systemic Sclerosis: A Pilot Study.

Murphy SL, Barber MW, Homer K, Dodge C, Cutter GR, Khanna D. Murphy SL, et al. Arthritis Care Res (Hoboken). 2018 Nov;70(11):1653-1660. doi: 10.1002/acr.23522. Arthritis Care Res (Hoboken). 2018. PMID: 29381834 Free PMC article.

5

Progressive Dyspnea With Recurrent Pneumothoraces.

Homer KL, Mandziuk J, Hirji A, Barrie J, Meyer SR, Wong EYL, Puttagunta L, Halloran KM. Homer KL, et al. Chest. 2021 Aug;160(2):e209-e215. doi: 10.1016/j.chest.2021.03.052. Chest. 2021. PMID: 34366047

6

Evidence for, and importance of, cGMP-independent mechanisms with NO and NO donors on blood vessels and platelets.

Wanstall JC, Homer KL, Doggrell SA. Wanstall JC, et al. Among authors: homer kl. Curr Vasc Pharmacol. 2005 Jan;3(1):41-53. doi: 10.2174/1570161052773933. Curr Vasc Pharmacol. 2005. PMID: 15638781 Review.

7

Platelet inhibitory effects of the nitric oxide donor drug MAHMA NONOate in vivo in rats.

Homer KL, Wanstall JC. Homer KL, et al. Eur J Pharmacol. 2003 Dec 15;482(1-3):265-70. doi: 10.1016/j.ejphar.2003.10.016. Eur J Pharmacol. 2003. PMID: 14660031

8

Inhibition of rat platelet aggregation by the diazeniumdiolate nitric oxide donor MAHMA NONOate.

Homer KL, Wanstall JC. Homer KL, et al. Br J Pharmacol. 2002 Dec;137(7):1071-81. doi: 10.1038/sj.bjp.0704971. Br J Pharmacol. 2002. PMID: 12429580 Free PMC article.

9

Cyclic GMP-independent relaxation of rat pulmonary artery by spermine NONOate, a diazeniumdiolate nitric oxide donor.

Homer KL, Wanstall JC. Homer KL, et al. Br J Pharmacol. 2000 Oct;131(4):673-82. doi: 10.1038/sj.bjp.0703613. Br J Pharmacol. 2000. PMID: 11030715 Free PMC article.

10

Inhibition by 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one (ODQ) of responses to nitric oxide-donors in rat pulmonary artery: influence of the mechanism of nitric oxide generation.

Homer KL, Fiore SA, Wanstall JC. Homer KL, et al. J Pharm Pharmacol. 1999 Feb;51(2):135-9. doi: 10.1211/0022357991772240. J Pharm Pharmacol. 1999. PMID: 10217311

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

10 results

Search Page

Filters